June 02, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The FDA approved Zaynich as an intravenous treatment for complicated urinary tract infections, including pyelonephritis, in adults, according to a press release from the antibiotic’s manufacturer, Wockhardt.“The threat of drug-resistant infections is an escalating crisis, leaving clinicians with fewer tools to treat patients facing these aggressive pathogens. The FDA approval of
June 02, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis

FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics market

Wockhardt secures US FDA approval for antibiotic Zaynich

Wockhardt gets CDSCO nod for Zaynich antibiotic

Wockhardt shares in focus after FDA approval for antibiotic targeting drug-resistant infections. Check details

Wockhardt marks research milestone with USFDA approval for novel antibiotic Zaynich

'USFDA nod for Zaynich a major boost'

Zaynich's blockbuster potential lifts Wockhardt's long-term outlook

Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibiotic

If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil Khorakiwala

Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of…

Wockhardts newly approved antibiotic Zaynich has the potential to transform the treatment of drug-resistant infections, according…

Wockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract…

Wockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be…

Wockhardt will be in focus after the US FDA approved ZAYNICH, a novel intravenous antibiotic combining cefepime and zidebactam…

Zaynich (cefepime and zidebactam) is an injectable antibiotic comprising cefepime, a cephalosporin antibacterial drug and…